On February 24, 2022, Double Medical Technology Inc. closed the transaction. The company has issued 12,000,000 A shares at a price of CNY 41.36 per A share for a total gross proceeds of CNY 496,320,000. The transaction included participation from Caitong Fund Management Co., Ltd. for 3,810,444 shares, UBS Group AG for 1,208,897 shares, Guotai Junan Securities Co., Ltd. for 991,295 shares, Hunan Development Group Capital Management Co., Ltd for 725,338 shares, JPMorgan Chase Bank, National Association for 725,338 shares, Jinan Hanxiang Investment Management Partnership Enterprise (Limited Partnership) for 725,338 shares, China International Capital Corporation Limited for 483,558 shares, Shandong Huihan Industry Development Co., Ltd. for 483,558 shares, Nuode Asset Management Co., Ltd. for 483,558 shares, Borui Oriental Value No.

19 Private Securities Investment Fund, a fund managed by Xiamen Borui Oriental Investment Management Co., Ltd. for 483,558 shares, No. 16 Asset Management Product of Advantage Enterprise, a fund managed by Generali China Asset Management Co., Ltd. for 483,558 shares, Ningju Kaiyang No. 10 Private Securities Investment Fund, a fund managed by Zhejiang Enjoy Investment Management Co,.

Ltd. for 483,558 shares, China Southern Asset Management Co., Ltd. for 428,444 shares and individual investor Dong Weiguo for 483,558 shares. The company has received CNY 487,217,033.23 after deducting of issuance fees., of which CNY 12,000,000 went to paid-in share capital and CNY 475,217,033.23 went to capital reserve of the company. All the securities issued will subject to a hold period of six month in the transaction.